| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 494 | 183 | 444 | 544 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 494 | 183 | 444 | 544 | | | Operating Expenses | | Research Development | 13,395 | 15,112 | 13,771 | 14,229 | | Selling General and Administrative | 3,499 | 3,828 | 3,378 | 4,018 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,400) | (18,757) | (16,705) | (17,703) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,206 | (1,623) | 602 | 93 | | Earnings Before Interest And Taxes | (15,194) | (19,724) | (16,759) | (17,610) | | Interest Expense | 30 | 34 | 52 | 22 | | Income Before Tax | (15,224) | (19,758) | (16,811) | (17,632) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,224) | (19,758) | (16,811) | (17,632) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,224) | (19,758) | (16,811) | (17,632) | | Preferred Stock And Other Adjustments |
-
| (190) |
-
|
-
| | | Net Income Applicable To Common Shares | ($15,224) | ($19,948) | ($16,811) | ($17,632) |
|
0.32% Nasdaq 
0.02 (0.37%) 
Income Statement
